Skip to main content

United States News All stories

Every story in this section, newest first — page 320 of 373.

Grafa
Health

Moderna and Merck sustain 49% risk reduction in milestone five-year cancer vaccine study

Moderna (NASDAQ:MRNA) and Merck (NYSE:MRK) announced Tuesday that their individualized neoantigen therapy continues to show dramatic long-term benefits, providing the strongest evidence to date that mRNA technology can be harnessed to treat established cancer.

Read more: Moderna and Merck sustain 49% risk reduction in milestone five-year cancer vaccine study
Grafa

Peoples Bancorp posts record Q4 net income of $31.8M

Marietta, Ohio-based Peoples Bancorp (NASDAQ:PEBO) reported strong fourth-quarter 2025 financial results, highlighted by record net income of $31.8 million, or $0.89 per diluted share, compared with $26.9 million ($0.76 per share) in the fourth quarter of 2024 and $29.5 million ($0.83 per share) in the third quarter of 2025.

Read more: Peoples Bancorp posts record Q4 net income of $31.8M